feed,title,long_url,short_url
Benzinga,A Look Into Guess Price Over Earnings,https://benzinga.com/news/earnings/21/08/22594439/a-look-into-guess-price-over-earnings,https://j.mp/2W5puTU
Benzinga,AstraZeneca's COVID-19 Antibody Cuts Risk Of Symptomatic Disease By 77%,https://benzinga.com/general/biotech/21/08/22592950/astrazenecas-covid-19-antibody-cuts-risk-of-symptomatic-disease-by-77,https://j.mp/3j04lD0
Benzinga,Why HEXO's Stock Is Getting Hammered Today,https://benzinga.com/news/21/08/22593947/why-hexos-stock-is-getting-hammered-today,https://j.mp/2XDAPL7
Benzinga,UK Approves Regeneron - Roche's COVID-19 Antibody Cocktail,https://benzinga.com/general/biotech/21/08/22592570/uk-approves-regeneron-roches-covid-19-antibody-cocktail,https://j.mp/3y4WoRs
Benzinga,Why Geovax Labs Shares Are Soaring Today,https://benzinga.com/general/biotech/21/08/22593661/why-geovax-labs-shares-are-soaring-today,https://j.mp/3z9FBxS
Benzinga,Price To Earnings Ratio Insights For LexinFintech,https://benzinga.com/news/earnings/21/08/22594458/price-to-earnings-ratio-insights-for-lexinfintech,https://j.mp/3swAVQe
